BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang XH, Liao B, Hu WJ, Tu CX, Xiang CL, Hao SH, Mao XH, Qiu XM, Yang XJ, Yue X, Kuang M, Peng BG, Li SQ. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus. Oncologist 2020;25:e1552-61. [PMID: 32663354 DOI: 10.1634/theoncologist.2019-0766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zeng ZM, Mo N, Zeng J, Ma FC, Jiang YF, Huang HS, Liao XW, Zhu GZ, Ma J, Peng T. Advances in postoperative adjuvant therapy for primary liver cancer. World J Gastrointest Oncol 2022; 14(9): 1604-1621 [DOI: 10.4251/wjgo.v14.i9.1604] [Reference Citation Analysis]
2 Cui H, Yang Y, Feng M, Gao Y, Li L, Tu W, Chen X, Hao B, Li S, Li D, Chen L, Zhou C, Cao Y. Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis. Translational Oncology 2022;22:101455. [DOI: 10.1016/j.tranon.2022.101455] [Reference Citation Analysis]
3 Tahreem B, Ali G, Ahmad H, Shahzad A, Khurram M, Naeem N, Nazar A, Haris M, . H, . S. Genotypes Variation and Molecular Epidemiology Of The Hbv Chronic Liver Infection In The Local Population Of Pakistan: An Overview Of The Recent Literature. PBMJ 2022. [DOI: 10.54393/pbmj.v5i4.372] [Reference Citation Analysis]
4 Hu S, Gan W, Qiao L, Ye C, Wu D, Liao B, Yang X, Jiang X. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE. Front Oncol 2021;11:742630. [PMID: 34745962 DOI: 10.3389/fonc.2021.742630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang Y, Zhou K, Wang X, Liu Y, Guo D, Bian Z, Su L, Liu K, Gu X, Guo X, Wang L, Zhang H, Tao K, Xing J. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments. Cancer Sci 2021. [PMID: 34490703 DOI: 10.1111/cas.15128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang JC, Hou JY, Chen JC, Xiang CL, Mao XH, Yang B, Li Q, Liu QB, Chen J, Ye ZW, Peng W, Sun XQ, Chen MS, Zhou QF, Zhang YJ. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. Eur J Cancer 2021;155:85-96. [PMID: 34371445 DOI: 10.1016/j.ejca.2021.07.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Guan MC, Ouyang W, Wang MD, Liang L, Li N, Fu TT, Shen F, Lau WY, Xu QR, Huang DS, Zhu H, Yang T. Biomarkers for hepatocellular carcinoma based on body fluids and feces. World J Gastrointest Oncol 2021; 13(5): 351-365 [PMID: 34040698 DOI: 10.4251/wjgo.v13.i5.351] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Huang ZX, Yuan S, Li D, Hao H, Liu Z, Lin J. A Nomogram to Predict Lifestyle Factors for Recurrence of Large-Vessel Ischemic Stroke. Risk Manag Healthc Policy 2021;14:365-77. [PMID: 33568955 DOI: 10.2147/RMHP.S289761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang J, Hou J, Chen J, Xiang C, Mao X, Yang B, Li Q, Liu Q, Chen J, Ye Z, Peng W, Chen M, Zhou Q, Zhang Y. Development and Validation of Prognostic Nomograms for BCLC A Stage Hepatocellular Carcinoma Beyond Milan Criteria after Curative Resection. SSRN Journal. [DOI: 10.2139/ssrn.3739823] [Reference Citation Analysis]